According to DBV Technologies's latest financial reports the company has $0.14 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.14 B | -32.42% |
2022-12-31 | $0.20 B | 170.62% |
2021-12-31 | $77.3 M | -67.99% |
2020-12-31 | $0.24 B | 11.56% |
2019-12-31 | $0.21 B | 34.75% |
2018-12-31 | $0.16 B | -19.1% |
2017-12-31 | $0.19 B | -30.06% |
2016-12-31 | $0.28 B | -26.55% |
2015-12-31 | $0.38 B | 128.12% |
2014-12-31 | $0.16 B | 125.52% |
2013-12-31 | $75.14 M | 12.01% |
2012-12-31 | $67.08 M | 246.35% |
2011-12-31 | $19.36 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Ionis Pharmaceuticals
IONS | $2.33 B | 1,549.04% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $2.37 B | 1,577.39% | ๐บ๐ธ USA |